Cargando…
Efficacy of Hydroxy-L-proline (HYP) analogs in the treatment of primary hyperoxaluria in Drosophila Melanogaster
BACKGROUND: Substrate reduction therapy with analogs reduces the accumulation of substrates by inhibiting the metabolic pathways involved in their biosynthesis, providing new treatment options for patients with primary hyperoxalurias (PHs) that often progress to end-stage renal disease (ESRD). This...
Autores principales: | Yang, Huan, Male, Musa, Li, Yang, Wang, Ning, Zhao, Chenming, Jin, Shan, Hu, Juncheng, Chen, Zhiqiang, Ye, Zhangqun, Xu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035412/ https://www.ncbi.nlm.nih.gov/pubmed/29980178 http://dx.doi.org/10.1186/s12882-018-0980-8 |
Ejemplares similares
-
Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria
por: Han, Shanfu, et al.
Publicado: (2019) -
HypDB: A functionally annotated web-based database of the proline hydroxylation proteome
por: Gong, Yao, et al.
Publicado: (2022) -
Complex formation constant of ferric ion with Gly, Pro-Hyp and Gly-Pro-Hyp
por: Zhi, Mingyu, et al.
Publicado: (2018) -
Enzymatic production of trans‐4‐hydroxy‐l‐proline by proline 4‐hydroxylase
por: Chen, Xiulai, et al.
Publicado: (2020) -
In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1
por: Christensen, Emily M., et al.
Publicado: (2021)